A Kansas City, Kan., cancer clinic agreed to pay $2.9 million to resolve allegations that it violated the False Claims Act by submitting claims to Medicare, Medicaid, and the Federal Employee Health Benefits Program without providing those drugs and services.
The word “alternative” may soon disappear from the name of the NIH National Center for Complementary and Alternative Medicine.
My name is Clifford Hudis, and I am a medical oncologist at Memorial Sloan Kettering Cancer Center where I am chief of the Breast Medicine Service. I am also professor of medicine at the Weill Cornell Medical College and president of ASCO. I have had an amazing year serving as the president of ASCO, and today I am delighted to welcome you to our society's 50th annual meeting commemorated in recent weeks by both the Congress of the United States and also by our host city, Chicago, and its Mayor, Mr. Rahm Emanuel.
Four Options in Colorectal CancerAnother practice-changing study—CALGB/SWOG 80405— sought to determine whether there is an optimal first-line treatment for patients with untreated metastatic colorectal cancer without KRAS mutations by comparing chemotherapy plus either bevacizumab or cetuximab.
CHICAGO—The consequences of diminishing federal support for cancer research can be measured in the abstracts presented at the 50th annual meeting of the American Society of Clinical Oncology that concluded earlier this week.
FDA approved the Amgen agent Vectibix (panitumumab) for use in combination with FOLFOX as first-line treatment in patients with wild-type KRAS (exon 2) metastatic colorectal cancer.
THE CENTERS FOR DISEASE CONTROL AND PREVENTION is recruiting for the position of Director of the Division of Cancer Prevention and Control in the National Center for Chronic Disease Prevention and Health Promotion.
THE MAYO CLINIC signed an agreement with N-of-One to provide access to clinical interpretation information to aid molecular diagnostics.
THE JAMES GRAHAM BROWN CANCER CENTER at the University of Louisville received a three-year, $5.5 million grant to develop new treatments and vaccines for various forms of cancer from the Leona M. and Harry B. Helmsley Charitable Trust.
MD ANDERSON CANCER CENTER signed an agreement with Concord Medical Services Holdings Limited to serve as a consultant for its cancer hospital projects under planning in Shanghai and Beijing.
